EVFM.US Evofem Biosciences Inc

Healthcare Pharmaceuticals USA Stocks
0.0058 USD
Close of Nov 13, 2026
0.0060 0.0140
Market cap
USD 769K
P/E
-
P/B
8.37x
ROE
-
Dividend yield
15.22%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is EVFM.US undervalued?

Graham number

The Graham number of Evofem Biosciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Evofem Biosciences Inc fundamental analysis

No fundamental analysis for Evofem Biosciences Inc yet.

Evofem Biosciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Evofem Biosciences Inc

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Full company profile